Planning study for available dose of hypoxic tumor volume using fluorine-18-labeled fluoromisonidazole positron emission tomography for treatment of the head and neck cancer

Radiotherapy and Oncology

Volumn 97, Issue 2, 2010, Pages 176-182

  Choi, Wonsik ^a   Lee, Sang Wook ^a   Park, Sung Ho ^a   Ryu, Jin Sook ^b   Oh, Seung Joon ^b   Im, Ki Chun ^b   Choi, Eun Kyung ^a   Kim, Jong Hoon ^a   Jung, Sang Hoon ^a   Kim, Sookon ^c   Ahn, Seung Do ^a  

^a University of Ulsan College of Medicine   (South Korea)

^b University of Ulsan   (South Korea)

^c Kangwon National University   (South Korea)

Author keywords

FMISO PET; Hypoxia; Intensity modulated radiotherapy

Indexed keywords

1 FLUORO 3 (2 NITRO 1 IMIDAZOLYL) 2 PROPANOL F 18;

ADULT; AGED; ARTICLE; CANCER STAGING; CLINICAL ARTICLE; COMPUTER ASSISTED EMISSION TOMOGRAPHY; FEMALE; HEAD AND NECK CANCER; HUMAN; HYPOXIA; INTENSITY MODULATED RADIATION THERAPY; LYMPH NODE METASTASIS; MALE; NASOPHARYNX CANCER; PRIORITY JOURNAL; RADIATION DOSE; TONSIL CANCER; TREATMENT PLANNING; TUMOR VOLUME;

ADULT; AGED; ANOXIA; FEMALE; FLUORODEOXYGLUCOSE F18; HEAD AND NECK NEOPLASMS; HUMANS; MALE; MIDDLE AGED; NEOPLASM STAGING; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS; RADIOTHERAPY DOSAGE; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; RADIOTHERAPY, INTENSITY-MODULATED; TOMOGRAPHY, X-RAY COMPUTED; TUMOR BURDEN;

EID: 78149357103     PISSN: 01678140     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.radonc.2010.04.012     Document Type: Article

References (34)

1. D.M. Brizel, S.P. Scully, and J.M. Harrelson Tumor oxygenation predicts for the likelihood of distant metastases in human soft tissue sarcoma Cancer Res 56 1996 941 943
2. D.M. Brizel, G.S. Sibley, L.R. Prosnitz, R.L. Scher, and M.W. Dewhirst Tumor hypoxia adversely affects the prognosis of carcinoma of the head and neck Int J Radiat Oncol Biol Phys 38 1997 285 289
3. M. Hockel, C. Knoop, and K. Schlenger Intratumoral pO2 predicts survival in advanced cancer of the uterine cervix Radiother Oncol 26 1993 45 50
4. M. Nordsmark, and J. Overgaard A confirmatory prognostic study on oxygenation status and loco-regional control in advanced head and neck squamous cell carcinoma treated by radiation therapy Radiother Oncol 57 2000 39 43
5. M. Nordsmark, S.M. Bentzen, and V. Rudat Prognostic value of tumor oxygenation in 397 head and neck tumors after primary radiation therapy. An international multi-center study Radiother Oncol 77 2005 18 24
6. P.L. Olive, R.E. Durand, J. Le Riche, I.A. Olivotto, and S.M. Jackson Gel electrophoresis of individual cells to quantify hypoxic fraction in human breast cancers Cancer Res 53 1993 733 736
7. P.L. Olive, T. Trotter, J.P. Banath, S.M. Jackson, and J. Le Riche Heterogeneity in human tumour hypoxic fraction using the comet assay Br J Cancer Suppl 27 1996 S191 S195
8. D.B. McLaren, T. Pickles, T. Thomson, and P.L. Olive Impact of nicotinamide on human tumour hypoxic fraction measured using the comet assay Radiother Oncol 45 1997 175 182
9. J.D. Chapman Hypoxic sensitizers - implications for radiation therapy N Engl J Med 301 1979 1429 1432
10. J.S. Rasey, W.J. Koh, J.R. Grierson, Z. Grunbaum, and K.A. Krohn Radiolabelled fluoromisonidazole as an imaging agent for tumor hypoxia Int J Radiat Oncol Biol Phys 17 1989 985 991
11. W.J. Koh, J.S. Rasey, and M.L. Evans Imaging of hypoxia in human tumors with [F-18]fluoromisonidazole Int J Radiat Oncol Biol Phys 22 1992 199 212
12. M.M. Graham, L.M. Peterson, and J.M. Link Fluorine-18-fluoromisonidazole radiation dosimetry in imaging studies J Nucl Med 38 1997 1631 1636
13. M. Piert, H. Machulla, and G. Becker Introducing fluorine-18 fluoromisonidazole positron emission tomography for the localisation and quantification of pig liver hypoxia Eur J Nucl Med 26 1999 95 109
14. M. Piert, H.J. Machulla, G. Becker, P. Aldinger, E. Winter, and R. Bares Dependency of the [18F]fluoromisonidazole uptake on oxygen delivery and tissue oxygenation in the porcine liver Nucl Med Biol 27 2000 693 700
15. J.G. Rajendran, D.L. Schwartz, and J. O'Sullivan Tumor hypoxia imaging with [F-18]fluoromisonidazole positron emission tomography in head and neck cancer Clin Cancer Res 12 2006 5435 5441
16. M. Zimny, B. Gagel, and E. Dimartino FDG-a marker of tumour hypoxia? A comparison with [(18)F]fluoromisonidazole and pO (2)-polarography in metastatic head and neck cancer Eur J Nucl Med Mol Imaging 33 2006 1426 1431
17. N. Lawrentschuk, A.M. Poon, and S.S. Foo Assessing regional hypoxia in human renal tumours using 18F-fluoromisonidazole positron emission tomography BJU Int 96 2005 540 546
18. B. Gagel, P. Reinartz, and E. Dimartino PO(2) polarography versus positron emission tomography ([(18)F] fluoromisonidazole, [(18)F]-2-fluoro- 2′-deoxyglucose). An appraisal of radiotherapeutically relevant hypoxia Strahlenther Onkol 180 2004 616 622
19. S.M. Eschmann, F. Paulsen, and M. Reimold Prognostic impact of hypoxia imaging with 18F-misonidazole PET in non-small cell lung cancer and head and neck cancer before radiotherapy J Nucl Med 46 2005 253 260
20. R.J. Hicks, D. Rischin, R. Fisher, D. Binns, A.M. Scott, and L.J. Peters Utility of FMISO PET in advanced head and neck cancer treated with chemoradiation incorporating a hypoxia-targeting chemotherapy agent Eur J Nucl Med Mol Imaging 32 2005 1384 1391
21. D. Rischin, R.J. Hicks, and R. Fisher Prognostic significance of [18F]-misonidazole positron emission tomography-detected tumor hypoxia in patients with advanced head and neck cancer randomly assigned to chemoradiation with or without tirapazamine: a substudy of Trans-Tasman Radiation Oncology Group Study 98.02 J Clin Oncol 24 2006 2098 2104
22. D. Thorwarth, S.M. Eschmann, F. Holzner, F. Paulsen, and M. Alber Combined uptake of [18F]FDG and [18F]FMISO correlates with radiation therapy outcome in head-and-neck cancer patients Radiother Oncol 80 2006 151 156
23. K.S. Chao, J.O. Deasy, and J. Markman A prospective study of salivary function sparing in patients with head-and-neck cancers receiving intensity-modulated or three-dimensional radiation therapy: initial results Int J Radiat Oncol Biol Phys 49 2001 907 916
24. N. Lee, P. Xia, and J.M. Quivey Intensity-modulated radiotherapy in the treatment of nasopharyngeal carcinoma: an update of the UCSF experience Int J Radiat Oncol Biol Phys 53 2002 12 22
25. S.W. Lee, G.M. Back, and B.Y. Yi Preliminary results of a phase I/II study of simultaneous modulated accelerated radiotherapy for nondisseminated nasopharyngeal carcinoma Int J Radiat Oncol Biol Phys 65 2006 152 160
26. M. Guerrero, X.A. Li, M.A. Earl, M. Sarfaraz, and E. Kiggundu Simultaneous integrated boost for breast cancer using IMRT: a radiobiological and treatment planning study Int J Radiat Oncol Biol Phys 59 2004 1513 1522
27. A. Lauve, M. Morris, and R. Schmidt-Ullrich Simultaneous integrated boost intensity-modulated radiotherapy for locally advanced head-and-neck squamous cell carcinomas: II - clinical results Int J Radiat Oncol Biol Phys 60 2004 374 387
28. R. Mohan, Q. Wu, M. Manning, and R. Schmidt-Ullrich Radiobiological considerations in the design of fractionation strategies for intensity-modulated radiation therapy of head and neck cancers Int J Radiat Oncol Biol Phys 46 2000 619 630
29. K.S. Chao, W.R. Bosch, and S. Mutic A novel approach to overcome hypoxic tumor resistance. Cu-ATSM-guided intensity-modulated radiation therapy Int J Radiat Oncol Biol Phys 49 2001 1171 1182
30. N.Y. Lee, J.G. Mechalakos, and S. Nehmeh Fluorine-18-labeled fluoromisonidazole positron emission and computed tomography-guided intensity-modulated radiotherapy for head and neck cancer: a feasibility study Int J Radiat Oncol Biol Phys 70 2008 2 13
31. K.S. Chao, G. Ozyigit, B.N. Tran, M. Cengiz, J.F. Dempsey, and D.A. Low Patterns of failure in patients receiving definitive and postoperative IMRT for head-and-neck cancer Int J Radiat Oncol Biol Phys 55 2003 312 321
32. M. Nordsmark, and J. Overgaard Tumor hypoxia is independent of hemoglobin and prognostic for loco-regional tumor control after primary radiotherapy in advanced head and neck cancer Acta Oncol 43 2004 396 403
33. J.G. Rajendran, K.R. Hendrickson, A.M. Spence, M. Muzi, K.A. Krohn, and D.A. Mankoff Hypoxia imaging-directed radiation treatment planning Eur J Nucl Med Mol Imaging 33 2006 44 53
34. R.A. Popple, R. Ove, and S. Shen Tumor control probability for selective boosting of hypoxic subvolumes, including the effect of reoxygenation Int J Radiat Oncol Biol Phys 54 2002 921 927